Home > Drug Search >
  • company_query: Adapt Pharma
  •   > 
Drug Filter
Category:
chemistry (5) biology (9)
Status:
Approved (2) Phase Ⅲ (1) Phase Ⅱ (5) Phase Ⅰ (4) IND Filing (2)
Clinical Stage:
Pending (1) Active (10)
Bio-Type:
Gene therapy (2) Cell therapy (1) CAR T cell therapy (1) Vaccine (2) Recombinant cytokines (1) Fusion protein (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (2) Acute myeloid Leukemia (AML) (1) Anemia (2) Gastric cancer (1) Opioid central depression (1) HIV infection (1) Lung cancer (1) Melanoma (1) Non-Hodgkin B-cell lymphomas (1) Solid tumours (3) Relapsed or refractory malignant lymphoma (1) Sarcoma (1) Diagnostic agents (1) Skin hypertrophic scars (1) Ebola virus disease (EVD) (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top